Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
585.14
492.80
543.93
483.94
317.79
177.21
74.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
585.14
492.80
543.93
483.94
317.79
177.21
74.87
Raw Material Cost
55.68
51.24
55.44
42.07
22.53
21.23
17.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
81.90
79.98
72.70
57.68
32.79
25.49
16.99
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.52
7.24
5.16
1.36
0.98
1.07
0.44
Selling and Distribution Expenses
375.30
312.50
352.46
295.77
220.56
149.41
52.37
Other Expenses
2.32
1.46
3.48
-0.94
0.65
1.49
1.01
Total Expenditure (Excl Depreciation)
550.61
465.52
520.55
387.46
283.37
212.09
97.16
Operating Profit (PBDIT) excl Other Income
34.5
27.3
23.4
96.5
34.4
-34.900000000000006
-22.3
Other Income
15.39
19.22
34.22
14.71
9.16
5.95
3.78
Operating Profit (PBDIT)
72.83
56.81
77.53
133.23
55.05
-14.69
-8.17
Interest
14.52
7.24
5.16
1.36
0.98
1.07
0.44
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
529.46
441.55
488.50
441.88
295.26
155.98
57.64
Depreciation
36.00
33.96
28.73
24.68
17.94
15.25
10.37
Profit Before Tax
22.30
15.62
43.65
107.19
36.13
-31.01
-18.99
Tax
6.58
4.18
17.07
-0.77
0.00
0.03
0.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.76
17.56
26.58
107.96
36.13
-31.04
-19.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.76
17.56
26.58
107.96
36.13
-31.04
-19.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.04
-6.11
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
15.72
11.44
26.58
107.96
36.13
-31.04
-19.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
924.68
916.91
881.63
844.66
376.97
340.84
194.48
Earnings per share (EPS)
0.05
0.04
0.07
0.27
0.09
-0.08
-0.05
Diluted Earnings per share
0.05
0.04
0.07
0.27
0.09
-0.08
-0.05
Operating Profit Margin (Excl OI)
3.66%
0.74%
2.68%
19.39%
8.79%
-20.25%
-29.82%
Gross Profit Margin
9.96%
10.06%
13.31%
27.25%
17.01%
-8.89%
-11.51%
PAT Margin
3.55%
3.56%
4.89%
22.31%
11.37%
-17.52%
-25.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 18.73% vs -9.40% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 37.72% vs -57.14% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 52.66% vs -13.16% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 101.39% vs 38.46% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Chengdu Olymvax Biopharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
585.14
0
585.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
585.14
0
585.14
Raw Material Cost
55.68
0
55.68
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
81.90
0
81.90
Power Cost
0
0
0.00
Manufacturing Expenses
14.52
0
14.52
Selling and Distribution Expenses
375.30
0
375.30
Other Expenses
2.32
0.00
2.32
Total Expenditure (Excl Depreciation)
550.61
0
550.61
Operating Profit (PBDIT) excl Other Income
34.54
0.00
34.54
Other Income
15.39
0
15.39
Operating Profit (PBDIT)
72.83
0
72.83
Interest
14.52
0
14.52
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
529.46
0
529.46
Depreciation
36.00
0
36.00
Profit Before Tax
22.30
0
22.30
Tax
6.58
0
6.58
Provisions and contingencies
0
0
0.00
Profit After Tax
20.76
0
20.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
20.76
0
20.76
Share in Profit of Associates
0
0
0.00
Minority Interest
-5.04
0
-5.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
15.72
0
15.72
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
924.68
0
924.68
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
3.66%
0%
0.00
3.66%
Gross Profit Margin
9.96%
0%
0.00
9.96%
PAT Margin
3.55%
0%
0.00
3.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 58.51 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 18.73% vs -9.40% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 1.57 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 37.72% vs -57.14% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.74 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 52.66% vs -13.16% in Dec 2023
Annual - Interest
Interest 1.45 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 101.39% vs 38.46% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.66%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
